- Investing Ideas
- /
- Global Healthcare Defensive Stocks
Global Healthcare Defensive Stocks
UPDATED Jul 01, 2022
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
30 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 600511China National Medicines | CNÂ¥26.78 | -0.3% | -16.5% | CNÂ¥20.2b | CNÂ¥39.20 | PE11x | E9.7% | 2.6% | ||
| 600511China National Medicines | CNÂ¥26.76 | -0.3% | -16.5% | CNÂ¥20.2b | CNÂ¥39.20 | PE11x | E9.7% | 2.6% | ||
| UK2Shandong Weigao Group Medical Polymer | HK$1.04 | 0% | -46.2% | HK$41.7b | HK$1.30 | PE15.9x | E13.2% | 2.0% | ||
| A58Elevance Health | US$461.50 | 3.1% | 43.0% | US$116.3b | US$528.80 | PE18.6x | E10.6% | 1.1% | ||
| E1LV34Elevance Health | US$503.46 | 8.2% | 30.3% | US$117.2b | US$572.85 | PE18.8x | E10.6% | 1.1% | ||
| NHNK.YNihon Kohden | JPÂ¥10.13 | -3.3% | -31.2% | JPÂ¥233.2b | JPÂ¥13.58 | PE10x | E-4.3% | 1.4% | ||
| ELV *Elevance Health | US$9,795.16 | 4.8% | 27.6% | US$116.3b | US$11,222.99 | PE18.6x | E10.6% | 1.1% | ||
| 6849Nihon Kohden | JPÂ¥2,773.00 | -2.6% | -13.2% | JPÂ¥233.2b | JPÂ¥3,716.67 | PE10x | E-4.3% | 1.4% | ||
| ELVElevance Health | US$485.98 | 3.4% | 25.5% | US$117.2b | US$552.96 | PE18.8x | E10.6% | 1.1% | ||
| PD1Ansell | AU$56.50 | 2.7% | -44.9% | AU$2.8b | AU$74.71 | PE8.7x | E3.1% | 4.5% | ||
| PD1AAnsell | AU$14.47 | 3.4% | -44.3% | AU$2.8b | AU$19.14 | PE8.7x | E3.1% | 4.5% | ||
| NHNK.FNihon Kohden | JPÂ¥22.00 | 0% | n/a | JPÂ¥233.2b | JPÂ¥29.49 | PE10x | E-4.3% | 1.4% | ||
| ANSL.YAnsell | AU$61.48 | 2.2% | -51.7% | AU$2.8b | AU$81.28 | PE8.7x | E3.1% | 4.5% | ||
| PINCPremier | US$36.23 | -2.5% | 2.3% | US$4.3b | US$41.09 | PE15x | E-2.9% | 2.2% | ||
| ANNAnsell | AU$22.14 | 1.4% | -46.8% | AU$2.8b | AU$29.27 | PE8.8x | E3.1% | 4.4% | ||
| ANNAnsell | AU$22.43 | 2.9% | -46.0% | AU$2.8b | AU$29.52 | PE8.9x | E3.1% | 4.4% | ||
| 1066Shandong Weigao Group Medical Polymer | HK$9.12 | -1.3% | -48.2% | HK$41.7b | HK$11.41 | PE15.9x | E13.2% | 2.0% | ||
| SHWG.YShandong Weigao Group Medical Polymer | HK$4.77 | 5.8% | -47.6% | HK$41.7b | HK$5.97 | PE15.9x | E13.2% | 2.0% | ||
| SHWG.FShandong Weigao Group Medical Polymer | HK$1.06 | 0% | -57.3% | HK$41.7b | HK$1.33 | PE15.9x | E13.2% | 2.0% | ||
| 600998Jointown Pharmaceutical Group | CNÂ¥11.91 | -1.7% | -21.3% | CNÂ¥22.0b | CNÂ¥13.40 | PE10.3x | E20.5% | 2.5% | ||
| ANSL.FAnsell | AU$17.46 | 0% | n/a | AU$2.8b | AU$23.09 | PE8.7x | E3.1% | 4.5% | ||
| 1066Shandong Weigao Group Medical Polymer | HK$9.12 | -1.3% | -48.2% | HK$41.7b | HK$11.41 | PE15.9x | E13.2% | 2.0% | ||
| 600998Jointown Pharmaceutical Group | CNÂ¥11.88 | -1.9% | -21.5% | CNÂ¥21.9b | CNÂ¥13.40 | PE10.2x | E20.5% | 2.5% | ||
| NHCNational HealthCare | US$70.89 | 1.6% | 0.9% | US$1.1b | n/a | PE8.3x | n/a | 3.1% |